unknown
Stage
About
CrystalsFirst GmbH provides a platform that leverages patented high-throughput structural biology combined with AI-powered drug design to accelerate small-molecule drug discovery, enabling ligand identification and optimization through structural biology and fragment screening.
Explore CrystalsFirst GmbH's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.